{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:09:15Z","timestamp":1794265755100,"version":"4.9.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Temporary mechanical circulatory support (t-MCS) with Impella CP has recently attracted considerable interest as a therapeutic option for cardiogenic shock (CS) complicating acute myocardial infarction (AMI). In contrast, evidence regarding the use of the larger Impella 5+ (5.0\/5.5) in this clinical setting remains limited. This single-centre retrospective study aimed to evaluate the clinical impact of Impella 5+ in patients with AMI-related cardiogenic shock (AMI-CS)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Between January 2022 and August 2024, 28 patients referred for AMI-CS were treated with Impella 5+. 11 patients were classified as SCAI C, 11 as SCAI D and 6 as SCAI E. On admission, median inotropic score was 10.5 and median left ventricular ejection fraction was 17.5%. 12 patients required concomitant ECMO support (ECPella). 19 patients were escalated from IABPM to Impella 5+. The median length of support was 8 days, 2 patients (7%) received the support for more than 30 days. 1 patient experienced a major bleeding complication. The overall survival during index hospitalization was 79%: 3 patients were bridged to a durable left ventricular assist device (LVAD) and 2 received heart transplantation (HTx).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Impella 5+ appears to be a safe and effective option in AMI-CS, associated with improved survival and a relatively low incidence of vascular and non-vascular complications. Its advanced features broaden the therapeutic potential of microaxial flow pumps in this high-risk setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1840979","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:26:29Z","timestamp":1784636789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcomes of Impella 5+ in acute myocardial infarction-related cardiogenic shock: a retrospective single-center study"],"prefix":"10.3389","volume":"13","author":[{"given":"Giulia","family":"Maj","sequence":"first","affiliation":[{"name":"Cardiothoracic and Vascular Anesthesia and Intensive Care, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Piermartiri","sequence":"additional","affiliation":[{"name":"Cardiology Department, IRCCS Policlinico Sant\u2019Orsola, University Hospital of Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Querio","sequence":"additional","affiliation":[{"name":"Cardiothoracic and Vascular Anesthesia and Intensive Care, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bandini","sequence":"additional","affiliation":[{"name":"Cardiothoracic Intensive Care Department, Royal Papworth Hospital","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Department and Cardiac Surgery Unit, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Elia","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Department and Cardiac Surgery Unit, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Penpa","sequence":"additional","affiliation":[{"name":"Research and Innovation Department (DAIRI), University Hospital SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mazzucco","sequence":"additional","affiliation":[{"name":"Research and Innovation Department (DAIRI), University Hospital SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pappalardo","sequence":"additional","affiliation":[{"name":"Kore University","place":["Enna, Italy"]},{"name":"Policlinico Centro Cuore GB Morgagni","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Cavozza","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Department, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Gallo","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Department, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Audo","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Department, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[{"name":"Department of Traslational Medicine, Univeristy of Eastern Piedmont","place":["Novara, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioel Gabrio","family":"Secco","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Department and Cardiac Surgery Unit, AOU SS Antonio e Biagio e Cesare Arrigo","place":["Alessandria, Italy"]},{"name":"Department of Traslational Medicine, Univeristy of Eastern Piedmont","place":["Novara, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S2213-2600(21)00172-7","article-title":"Optimising trials in cardiogenic shock complicating acute myocardial infarction: a statement from the 2020 critical care clinical trialists workshop","volume":"9","author":"Arrigo","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ejhf.1750","article-title":"Trends in cardiogenic shock complicating acute myocardial infarction","volume":"22","author":"Aissaoui","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the society of critical care medicine (SCCM), and the society of thoracic surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"856870","DOI":"10.3389\/fcvm.2022.856870","article-title":"Ventricular unloading using the ImpellaTM device in cardiogenic shock","volume":"9","author":"Attinger-Toller","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0391398817752575","article-title":"Maximum level of mobility with axillary deployment of the impella 5.0 is associated with improved survival","volume":"41","author":"Esposito","year":"2018","journal-title":"Int J Artif Organs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ihj.2017.05.011","article-title":"The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock","volume":"69","author":"Esposito","year":"2017","journal-title":"Indian Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction: a pilot study using the impella CP","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1002\/ejhf.3544","article-title":"Midterm outcomes of patients with native heart recovery after Impella 5+ for cardiogenic shock","volume":"27","author":"Bandini","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.healun.2024.05.015","article-title":"Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: a report from the cardiogenic shock working group","volume":"43","author":"Fried","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1536\/ihj.24-385","article-title":"Association between Impella device type and short-term prognosis in patients with acute myocardial infarction-related cardiogenic shock receiving ECPELLA support","volume":"65","author":"Nakamura","year":"2024","journal-title":"Int Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.17925\/HI.2020.14.2.92","article-title":"A review of bleeding risk with Impella-supported high-risk percutaneous coronary intervention","volume":"14","author":"Vetrovec","year":"2020","journal-title":"Heart Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.3390\/jcm9123803","article-title":"Long-term clinical outcome of cardiogenic shock patients undergoing impella cp treatment vs. Standard of care","volume":"9","author":"Scherer","year":"2020","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1018203","DOI":"10.3389\/fcvm.2023.1018203","article-title":"Single center experience and early outcomes of Impella 5.5","volume":"10","author":"Funamoto","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/aor.14861","article-title":"Axillary artery access considerations in Impella 5.5 insertion: insights from exclusive axillary approach for successful support","volume":"49","author":"Khan","year":"2024","journal-title":"Artif Organs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"A35","DOI":"10.1093\/eurheartj\/suab007","article-title":"Escalation and de-escalation of mechanical circulatory support in cardiogenic shock","volume":"23","author":"Bertoldi","year":"2021","journal-title":"Eur Heart J Suppl"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1840979\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:26:30Z","timestamp":1784636790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1840979\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2026.1840979"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1840979","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcvm.2026.1840979.s001","asserted-by":"subject"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1840979"}}